Approval · Notice of Compliance 13471 · 2012
TYGACIL: Notice of Compliance 13471
Issued July 9, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13471
- Date
- July 9, 2012
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- ALternate site for the manufacture, primary packaging and testing of Tygacil
- Therapeutic class
- Tetracylcine Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TYGACIL | Not yet assigned | — |
Medicinal ingredients
- TIGECYCLINE 50 MG per VIAL